We also identified a potential beneficial effect of the major allele at FGF21 rs838133 on cardiovascular outcomes, with the strongest association for venous thromboembolism, as well as on Alzheimer’s disease and lifespan. The gene discussed is FGF21; the disease is venous thromboembolism.